glp 1 studies Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature GLP-1 Genetics: How Genes Affect

The connection is so strong that many consider Alzheimer's Disease to be "diabetes of the brain", or "Type 3 Diabetes"

In addition, there is a likely analogy (see for review i.e., (Seiwerth et al., 2018)) with the attenuated fibrosis and scar formation in other tissues (i.e., the skin, muscle, tendon, and ligament) (Mikus et al., 2001

This approach differs from both traditional immunosuppression and even newer biologics

Moreover, promising outcomes from various large-scale cardiovascular outcome trials (CVOTs) have indicated that GLP-1RAs could mitigate the risk of major adverse cardiovascular events (MACE) in T2DM patients with an elevated cardiovascular risk profile (Marso et al., 2016a